Novartis Pharma S.A.E confirms all company products in Egypt unaffected by valsartan recall
Cairo, July 31, 2018 – Novartis Pharma S.A.E (Novartis Pharma) confirms that none of its products in Egypt are affected by the decision to recall certain products containing valsartan
